Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India

One-Year Follow-up of Immunocompetent Male Patients Treated With Miltefosine For Primary Visceral Leishmaniasis in Bihar, India

(2013) S. Burza et al.   CLINICAL INFECTIOUS DISEASES

Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance

(2013) Suman Rijal et al.   CLINICAL INFECTIOUS DISEASES

Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use

(2012) S. Sundar et al.   CLINICAL INFECTIOUS DISEASES

Liposomal amphotericin B as a treatment for human leishmaniasis

(2012) Manica Balasegaram et al.   EXPERT OPINION ON EMERGING DRUGS

Leishmaniasis Worldwide and Global Estimates of Its Incidence

(2012) Jorge Alvar et al.   PLoS One

Low castes have poor access to visceral leishmaniasis treatment in Bihar, India

(2012) F. Pascual Martínez et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis

(2012) Vasundhra Bhandari et al.   PLoS Neglected Tropical Diseases

Liposomal Amphotericin B for Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients: 2-Year Treatment Outcomes in Bihar, India

(2011) P. K. Sinha et al.   CLINICAL INFECTIOUS DISEASES

Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial

(2011) Shyam Sundar et al.   LANCET

Estimation of Under-Reporting of Visceral Leishmaniasis Cases in Bihar, India

(2010) Vijay P. Singh et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, India

(2010) Prabhat K. Sinha et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India

(2010) Shyam Sundar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk factors for visceral leishmaniasis in India: further evidence on the role of domestic animals

(2010) S. P. Singh et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent

(2010) Filip Meheus et al.   PLoS Neglected Tropical Diseases

Decomposing malnutrition inequalities between Scheduled Castes and Tribes and the remaining Indian population

(2009) Ellen Van de Poel et al.   ETHNICITY & HEALTH

The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India

(2009) M. Boelaert et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Pharmacokinetics of Miltefosine in Old World Cutaneous Leishmaniasis Patients

(2008) T. P. C. Dorlo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Relationship between Leishmaniasis and AIDS: the Second 10 Years

(2008) J. Alvar et al.   CLINICAL MICROBIOLOGY REVIEWS